This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Fukuoka University, Lsi Medience Corporation, Phc Corporation. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018-2026
Title: Hiroyasu Ishikura: Innovating in the Field of Medicine
Introduction
Hiroyasu Ishikura, a notable inventor from Fukuoka, Japan, has made significant contributions to the medical field with his innovative patent. His work primarily focuses on the diagnosis and treatment of infectious disseminated intravascular coagulation (DIC), a critical condition that affects many patients.
Latest Patents
Ishikura holds one patent titled "Method of diagnosing and treating infectious disseminated intravascular coagulation." This innovative method provides markers useful in diagnosing DIC or infectious DIC. In his discovery, he presents a technique for detecting DIC by measuring sCD14-ST in a sample. Furthermore, for the detection of infectious DIC, both sCD14-ST and a coagulation-related marker are assessed in a sample, enhancing the accuracy of diagnosis.
Career Highlights
Throughout his career, Hiroyasu Ishikura has made noteworthy strides in his field. He has worked for reputable institutions such as LSI Medience Corporation and Fukuoka University. His experience in these organizations has significantly influenced his research and development efforts, allowing him to translate complex medical challenges into innovative solutions.
Collaborations
Ishikura's collaborations with LSI Medience Corporation and Fukuoka University demonstrate his commitment to advancing healthcare technology. By partnering with these institutions, he has been able to leverage their resources and expertise to further his research on DIC and its implications in infectious diseases.
Conclusion
Hiroyasu Ishikura stands out as a prominent inventor in the medical arena, with his impactful patent addressing critical health issues. His ongoing contributions not only enhance our understanding of DIC but also pave the way for future innovations in diagnostics and treatment in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile